Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim
Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.
This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesize, profile, and then characterize a wide range of chemotypes against key targets of interest in swift optimization cycles. The partnership also allows for the integrated up-scaling of compounds for larger pre-clinical studies. Biology screening of appropriate chemical moieties to drive decision making with speed and accuracy is also included in the partnership. Aragen will dedicate a sizeable portion of its campus in Hyderabad to support this alliance.
"We at Aragen believe that ‘In Every Molecule is the Possibility for Better Health’, and are excited about the opportunity to expand our partnership with Boehringer Ingelheim, a global leader in the discovery and development of novel medicines. It has been our privilege to collaborate with the scientists at Boehringer Ingelheim, and we thank them for their trust and confidence in the Aragen team. Together, we look forward to advancing Boehringer Ingelheim’s innovative approaches into successful clinical outcomes that can have the potential to ultimately benefit patients,” said Manni Kantipudi, CEO at Aragen .
Aragen Life Sciences Pvt Ltd (“Aragen”) is a global leader in providing discovery, development and manufacturing solutions for life sciences firms. With a team of over 3100 professionals, and through a network of sites around the world, we offer a seamless, integrated platform to advance customer programs from discovery through commercialization for both small molecules and biologics. Established in 2001, Aragen now serves over 450 customers worldwide across multiple modalities and therapeutic areas. For more information, visit www.aragen.com
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OBILET4.8.2021 11:02:07 CEST | Press release
European Online Travel Champion obilet.com Ready for Record Growth
EXSCIENTIA4.8.2021 10:02:12 CEST | Press release
Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline
SMARTSTREAM-TECHNOLOGIES4.8.2021 10:02:12 CEST | Press release
SmartStream hires Mark Morris to meet increased demand in Managed Services
THALES4.8.2021 09:58:10 CEST | Press release
Thales Enters Into Agreement in View of Selling Its Ground Transportation Systems Business to Hitachi Rail
CA-DEEL4.8.2021 09:08:11 CEST | Press release
Deel, the Leading Platform for Global Hiring and Payments, Acquires Zeitgold to Strengthen Payroll & AI Offerings
SES4.8.2021 07:32:09 CEST | Press release
SES H1 2021 Results
CA-NEXON-AMERICA-INC.4.8.2021 07:02:08 CEST | Press release
Highly Anticipated Mobile RPG KonoSuba: Fantastic Days Launches August 19
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom